The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis

BACKGROUND: In chronic diseases such as multiple sclerosis requiring lifelong treatment, studies on long-term outcomes are important. OBJECTIVE: To assess disability and magnetic resonance imaging-related outcomes in relapsing multiple sclerosis patients from a Phase 2 study of fingolimod 10 or more...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mult Scler J Exp Transl Clin
Glavni autori: Derfuss, T, Sastre-Garriga, J, Montalban, X, Rodegher, M, Wuerfel, J, Gaetano, L, Tomic, D, Azmon, A, Wolf, C, Kappos, L
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Original Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7132565/
https://ncbi.nlm.nih.gov/pubmed/32284874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320907951
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items